Point of Care Diagnostics Market in the US:

Product Code SEL00029
Publication Date August 2006
Publisher Select Biosciences
Product Type Report
Pages 153
ISBN Number not applicable
Change currency
PDF £1,870.00 €2,252 $2,957 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Point of Care Diagnostics Market in the US:

This new report is the ideal tool for planning for success. The comprehensive analysis of the US market is based on (1) a proprietary comprehensive database of tests, (2) discussions with clinicians, (3) detailed assessments of current and emerging technologies, and (4) CDC, FDA, and professional organizational guidelines and publications. Twenty-one figures, 32 tables, and 57 company profiles present the information in a clear and accessible manner. "Point of Care Diagnostics Market in the US: Opportunities and Challenges" is the go-to tool for those wishing to enter and those wishing to stay current in this dynamic market.

Key Highlights of this report:

  • Comprehensive proprietary database of point of care diagnostics
  • Detailed analyses of performance of tests and technologies
  • Detailed pricing information
  • Segmentation by therapeutic area and by technology
  • Segmentation by instrumentation and tests
  • Regulatory hurdles
  • Key trends and market drivers
  • Opportunities and unmet needs
  • Quantitative market model

Contents

  • Executive Summary 111000
  • Introduction 111333
    • Figure 1 - Examples Of Tests Performed In Various Point Of Care Settings
    • Figure 2 - Logic Tree For Determining If A Diagnostic Is Appropriate For Use As A POCT
  • Technologies Use in point OF care Testing 111666
  • Introduction
    • Figure 3 - A Variety Of Technologies Are Used In POC Testing
  • Immunoassays
    • Figure 4 - Solid Phase Or Dipstick Immunoassay
    • Figure 5 - Agglutination Test
    • Figure 6 - Lateral Flow Test
  • Enzymatic assays
    • Figure 7 - Example Of An Enzymatic Reaction Used To Measure Glucose
  • Chemical measurements
  • Amperometric methods-electrodes
    • Figure 8 - Clark-Type Oxygen Sensing Electrode
  • information Technology and data integration 222444
  • Information Technology and Data Management Companies Serving the Point of Care Market
  • regulatory compliance for point of care testing 222666
  • point of care tests on the market by application 222999
  • Asthma
  • Theophylline Testing
    • Table 1 - POC Theophylline Test
  • Blood Gas Measurements
  • Blood Electrolyte Testing
  • Hemoglobin
    • Table 2 - POC Blood Gas, Electrolyte And Hemoglobin Tests
  • Cardiovascular Disease
  • BNP- B -Type Natriuretic Peptide, a Biochemical Marker for Heart Failure
    • Table 3 - Point of Care Tests for BNP
  • CK-MB
  • Troponins
  • Myoglobin
    • Table 4 - POC Tests for Markers Associated with Acute Cardiac Syndrome
  • Cholesterol and Triglycerides
    • Table 5 - POC Tests to Measure Cholesterol and Lipids
  • Kidney Disease
  • Urinary albumin
    • Table 6 - Point of Care Tests for Microalbuminuria
  • Diabetes
  • Glucose Monitoring
    • Table 7 - Bedside Glucose Monitors
  • Glycosylated Hemoglobin (glycohemoglobin, hemoglobin A1c)
    • Table 8 - POC HbA1c Tests
  • Urine and Blood Ketones
    • Table 9 - POC Tests for Blood Ketones
  • Hemostasis
  • aPTT-Activated Partial Thromboplastin Time Test
  • ACT-Activated Clotting Time Test
  • PT-Prothrombin Time, International Normalized Ratio
    • Table 10 - POC Blood Clotting Tests
  • D-dimer
    • Table 11 - POC D-Dimer Tests
  • Platelet Function Tests
    • Table 12 - POC Platelet Function Tests
  • Infectious Disease
  • Lyme Disease
    • Table 13 - POC Test for Detection of Borrelia burgdorferi
  • Chlamydia
    • Table 14 - POC Tests for Detection of Chlamydial Infection
  • Clostridium difficile
    • Table 15 - POC Tests for Detection of Clostridium difficile
  • H. pylori
    • Table 16 - POC Tests for Detection of H. Pylori
  • HIV
    • Table 17 - POC Tests for HIV
  • Infectious Mononucleosis
    • Table 18 - POC Tests for Infectious Mononucleosis
  • Infectious Vaginitis
    • Table 19 - POC Tests for Infectious Vaginitis
  • Influenza
    • Table 20 - POC Tests for Influenza
  • Legionella pneumophila
    • Table 21 - POC Test for Legionella pneumophila
  • RSV
    • Table 22 - POC Tests for RSV
  • Streptococcal Infections-StrepA
    • Table 23 - POC Tests for Streptococcus pyogenes
  • Trichomonas Vaginitis
    • Table 24 - POC Test for Trichomonas vaginitis
  • Inflammatory disease
  • CRP-C-reactive Protein
    • Table 25 - POC Tests for C-Reactive Protein
  • Perinatal, Neonatal care
  • Hyperbilirubinemia
    • Table 26 - POC Bilirubin Tests
  • ROM
    • Table 27 - POC Test for Ruptured Fetal Membranes
  • Oncology
  • Alpha-fetoprotein (AFP) Blood Test
    • Table 28 - POC Test for Alpha-fetoprotein
  • PSA
    • Table 29 - POC Tests for Prostate Specific Antigen
  • NMP22
    • Table 30 - POC Tests for NMP22
  • Fecal Occult Blood
    • Table 31 - POC Tests for Fecal Occult Blood
  • Trends and unmet needs 777888 I
  • market drivers 888000
  • market model 888777
  • Aggregate Market
    • Figure 9 - Numbers of Companies with Offerings
    • Figure 10 - Numbers of Point of Care Tests Offered by Indication
  • Market Sizes and Trends
    • Figure 11 - Market Sizes for POCT Addressing Cardiovascular Health, Inflammation, Asthma
    • Figure 12 - Market Sizes for POCT Addressing Infectious Diseases
    • Figure 13 - Market Sizes for POCT in Support Of Diabetes Treatment
    • Figure 14 - Market Sizes for POCT Assisting in The Diagnosis Of Cancer
    • Figure 15 - Market Sizes For Instrumentation Supporting POCT
  • Test Costs
    • Figure 16 - List Prices for POCTs Addressing Infectious Disease
    • Figure 17 - List Prices for POCT Addressing Cardiovascular Disease, Hemostasis And
  • Inflammatory Disease
    • Figure 18 - List Prices for POCT Aiding In The Management Of Diabetes
    • Figure 19 - List prices of Instrumentation Supporting Cardiovascular Disease, Hemostasis And
  • Inflammatory Disease POCT
    • Figure 20 - List Prices for POC Instruments And Monitors Aiding In The Management Of Diabetes
  • Incidence and Prevalence of Indications Served by Point of Care Testing
    • Figure 21 - US Incidence Of Acute Disease Indications Supported By POCT
    • Figure 22 - US Prevalence Of Chronic Diseases Supported By POC Diagnostics
  • appendix I-Methodology 111000111 I II
  • Author Credentials
  • Market Model
  • Sources
  • appendix X II-- list of 2006 clia--waived tests 111000333
  • Hematology
  • Urinalysis/Clinical Microscopy
  • Chemistry
  • Toxicology
  • Bacteriology
  • Virology
  • Immunology
    • Appendix III company profiles 111111777
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company
  • Company